Day One Biopharmaceuticals DAWN Price Prediction

The determination to procure Day One Biopharmaceuticals is entirely contingent on your individualistic risk tolerance. As you may discern, Day One Biopharmaceuticals's value has experienced a fall of -2.03% during the preceding 24 hours, and Day One Biopharmaceuticals has incurred a growth of 22.56% over the prior 30-day duration. Consequently, the determination of whether or not to invest in Day One Biopharmaceuticals will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of Day One Biopharmaceuticals may potentially surge to $10.80 by the end of this year. Looking at Day One Biopharmaceuticals's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $10.70. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental Day One Biopharmaceuticals forecast, the price of Day One Biopharmaceuticals will fall by -0.68% over the next week and reach $9.12 by January 15, 2026.

Based on the our new experimental Day One Biopharmaceuticals forecast, the price of Day One Biopharmaceuticals will increase by 0.9% over the next month and reach $9.26 by February 7, 2026.

As per our most recent prediction on Day One Biopharmaceuticals's value in 2026, DAWN is anticipated to fluctuate within the range of $9.03 and $10.80. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected Day One Biopharmaceuticals price forecast fails to consider sudden and extreme price fluctuations.

Day One Biopharmaceuticals's future appears to be on an upward trend, with an maximum price of $10.70 projected after a period of five years. Based on the Day One Biopharmaceuticals forecast for 2031, Day One Biopharmaceuticals's value may potentially reach its highest peak of approximately $10.70, while its lowest peak is anticipated to be around $9.91.

Based on the our new experimental Day One Biopharmaceuticals price prediction simulation, DAWN’s value in 2026 expected to grow by 17.7% to $10.80 if the best happened. The price will be between $10.80 and $9.03 during 2026.

According to our latest experimental simulation for Day One Biopharmaceuticals price prediction, DAWN’s value could rise by 22.2% to $11.21 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $11.21 and $9.74 throughout the year.

Our new experimental Day One Biopharmaceuticals price prediction model suggests that DAWN’s value in 2028 could increase by 10.31% , reaching $10.12 in the best-case scenario. The price is expected to range between $10.12 and $8.22 during the year.

Based on our experimental forecast model, Day One Biopharmaceuticals's value may experience a 1.12% growth in 2029, potentially reaching $9.28 under optimal conditions. The predicted price range for 2029 lies between $9.28 and $8.23.

Using our new experimental simulation for Day One Biopharmaceuticals price predictions, DAWN’s value in 2030 is expected to rise by 12.72% , reaching $10.34 in the best scenario. The price is forecasted to range between $10.34 and $8.69 over the course of 2030.

Our experimental simulation indicates that Day One Biopharmaceuticals’s price could grow by 16.6% in 2031, potentially hitting $10.70 under ideal conditions. The price will likely fluctuate between $10.70 and $9.91 during the year.

Based on the findings from our latest experimental Day One Biopharmaceuticals price prediction, DAWN could see a 29.94% rise in value, reaching $11.92 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $11.92 and $10.52 throughout the year.

According to our experimental Day One Biopharmaceuticals price prediction, DAWN’s value is anticipated to rise by 49.62% in 2033, with the highest potential price being $13.73. Throughout the year, DAWN’s price could range from $13.73 and $11.95.

The results from our new Day One Biopharmaceuticals price prediction simulation suggest that DAWN may rise by 64.18% in 2034, potentially reaching $15.07 under the best circumstances. The predicted price range for the year is between $15.07 and $13.37.

Based on our experimental forecast for Day One Biopharmaceuticals’s price, DAWN could grow by 88.33% , with the value potentially hitting $17.28 in 2035. The expected price range for the year lies between $17.28 and $14.50.

Our recent Day One Biopharmaceuticals price prediction simulation suggests that DAWN’s value might rise by 132.28% in 2036, possibly reaching $21.32 if conditions are optimal. The expected price range for 2036 is between $21.32 and $16.74.

According to the experimental simulation, Day One Biopharmaceuticals’s value could rise by 170.52% in 2037, with a high of $24.83 under favorable conditions. The price is expected to fall between $24.83 and $20.73 over the course of the year.